BreakThru SCI accelerates breakthrough spinal cord injury therapies in human clinical trials by mobilizing patient voice, engaging regulators, and amplifying meaningful clinical data to support an expedited and comprehensive regulatory review.

Breakthru SCI focuses specifically on the critical phase between successful human translation and regulatory approval - where promising therapies often stall without organized advocacy.

To do so, we:

- Amplify meaningful clinical data with structured, qualitative patient testimony
- Organize grassroots community engagement to demonstrate urgency and unmet need
- Engage regulators and policymakers to support expedited review pathways
- Host patient panels to surface real-world priorities that inform trial design and regulatory perspective

Our work ensures that breakthrough therapies showing meaningful human data move forward with the visibility, urgency, and patient-centered context they deserve.

BreakThru SCI

Org chart

Teams

Offices

BreakThru SCI

Org chart

Teams

Offices

Related companies